News

SamplesTogether will be powered by One Eleven’s SampleServer, e-sampling toolset used in pharmaceutical industry. SamplesTogether helps the pharmaceutical companies to optimize their sampling efforts by giving prescribers secure

The system’s workflow provides the flexibility to analyze data in as few as eight hours, or to generate in excess of 1 gigabase per run in slightly over

The company has also dosed first patient in the trial. The trial is designed to investigate the safety and escalating doses of OMP-59R5 in patients who have received

Sumavel DosePro is indicated for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache. Sumavel DosePro is a pre-filled, single-use

Ranibizumab, approved in UK as a treatment for wet age-related macular degeneration (AMD) under the brand name Lucentis. Ranibizumab was developed by Genentech and Novartis. Genentech has the

In the study, the major adverse cardiac events (MACE) free survival rate in patients treated with the Genous Stent was 80.6% after one year. The single-center study investigated

Established in San Francisco’s Mission Bay life sciences hub, the new Innovation Center comprises of scientists who are working for Bayer‘s hematology research program which is focused on

Under the agreement, Cephalon will use Celator’s proprietary technology in an ongoing drug development and life-cycle management program at Cephalon. Celator Pharma CEO Scott Jackson said they are

Regorafenib is an oral multi-kinase inhibitor, which targets angiogenic (VEGFR, TIE-2), stromal (PDGFR-ß) and oncogenic (RAF, RET and KIT) receptor tyrosine kinases. The randomised, double-blind, placebo-controlled, multi-centre, cross-over